(106 days)
The Omron Heat Pain Pro Model PM311B is intended for:
The relief of pain associated with sore or aching, muscles of the lower back, arm, legs, shoulder, or foot due to strain from exercise or normal household work activities.
When used for the symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis, use the Tap, Shoulder, Arm or Leg mode of stimulation.
The Heat Pain Pro (PM311B) is a small battery operated OTC device that provides a combination of transcutaneous electrical nerve stimulation (TENS) for pain relief and superficial heat for a warming sensation. It delivers TENS only or alternating combinations of TENS and heat are never applied at the same time. The device can connect to a specified external IEC 60601-1 compliant power supply for charging of the internal lithium ion batterv. The device complies with AAMI/ ANSI/ES60601-1, IEC 60601-1-2 and IEC 60601-2-10.
Stimulation from PM311B is intended for application to the following areas: lower back, arms, legs, shoulder or foot. Software controls and indicators. Software controls waveform characteristics.
The accessories include: An external power adaptor, an electrode cord / cable attached to electrodes pads and a Pad holder for storage. The electrode pads Omron "HV-PAD with PMGEL" allow for stimulation and have resistive elements to provide heat which is powered by the PM311B. These are the identical accessories cleared under K160115 for the Model PM311.
The device is battery powered and can be connected to an external power supply for charging the internal battery. The battery is lithium ion and is not user serviceable or accessible. The only external connections on the device are the power input and the electrode connector there is no connection to any other device.
The PM311B is identical to the PM311 cleared under 510(k) K160115, this submission is for expanded indications under product code NYN.
The PM311 and PM311B are considered - OTC devices.
The provided text is a 510(k) summary for the Omron Heat Pain Pro Model PM311B. It primarily focuses on demonstrating substantial equivalence to predicate devices, rather than detailed performance studies with acceptance criteria in the context of AI/ML devices. Therefore, much of the requested information regarding AI/ML device performance, ground truth establishment, expert adjudication, and comparative effectiveness studies is not applicable or available in this document.
However, I can extract information related to the device's technical specifications and how its performance is compared to predicate devices to establish substantial equivalence.
Here's a breakdown of the available and unavailable information based on your request:
1. Table of acceptance criteria and the reported device performance
The document does not explicitly state "acceptance criteria" in terms of statistical metrics (e.g., sensitivity, specificity, AUC) for an AI/ML device. Instead, the "acceptance criteria" appear to be based on demonstrating that the proposed device, PM311B, is substantially equivalent to its predicate devices (PM311 and Avail) in terms of:
- Indications for Use: The PM311B's expanded indication for chronic, intractable pain and arthritis pain relief is identical to the Avail (K172079) predicate. Otherwise, its indications are identical to the PM311 (K160115).
- Design and Technology: Identical to the PM311, and equivalent to the Omron Avail.
- Performance and Specifications: Identical to the PM311, and equivalent to the Omron Avail. This is primarily demonstrated through the detailed "Output Specification Comparison" tables (pages 10-12) which show the technical parameters of the electrical stimulation.
- Patient Population: Adult (identical to predicates).
- Environment of Use: Clinics, hospital, and home environments (identical to predicates).
- Compliance with Voluntary Standards: Adherence to AAMI ANSI ES6060-1, IEC 60601-1-2, IEC 60601-2-10, and IEC 60601-1-11 (identical to predicates).
Reported Device Performance (from "Output Specification Comparison" tables):
The PM311B is shown to have identical output specifications to its primary predicate, the Omron PM311 (K160115), across all tested parameters for its various modes (Tap, Knead, Rub, Arm, Lback, Leg, Foot, Joint, Shldr). These parameters include:
- Waveform (Biphasic, Rectangular shape)
- Maximum Output Voltage (@500Ω, @2kΩ, @10kΩ)
- Maximum Output Current (@500Ω, @2kΩ, @10kΩ)
- Duration of primary phase [usec]
- Pulse Duration [usec]
- Frequency [Hz]
- Net Charge (µC per pulse) (@500Ω) [µC]
- Maximum Phase Charge (@500Ω) [µC]
- Maximum Current Density (@500Ω) [mA/cm2] r.m.s.
- Maximum Average Current (average absolute value), mA
- Maximum Average Power Density (@500Ω) [W/cm²]
- Burst Mode parameters (N/A for this device)
- ON Time, OFF Time (N/A for this device)
The tables on pages 10 and 11 are identical, effectively stating that the PM311B's output is the PM311's output. The table on page 12 shows the specifications for the secondary predicate, Omron Avail (K172079), which has similar but not identical numerical values for some parameters, and also includes a "Microcurrent" mode not present in the proposed device. The "Discussion of Differences" column confirms that the proposed device, PM311B, is "Identical to predicate PM311 K160115" for almost all detailed features and electrical characteristics, except for the expanded indications for use, which are identical to the Avail.
2. Sample sized used for the test set and the data provenance
Not applicable. This device is an electrical nerve stimulator, not an AI/ML device relying on a "test set" in the context of diagnostic or prognostic model performance. The "testing" referred to is non-clinical engineering testing.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. No "ground truth" establishment by experts is described as this is not an AI/ML diagnostic or prognostic system.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. This is not an AI/ML device where adjudication of outputs would be relevant.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. No MRMC study was conducted as this is not an AI/ML device that assists human readers.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is not an AI/ML device with an algorithm for standalone performance. The device's "standalone" performance is its electrical output, which was tested against engineering standards and compared to predicates.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
Not applicable. No "ground truth" of this nature is relevant for this device type within the context of the provided document. The "truth" lies in its adherence to electrical safety and performance standards and its equivalence to legally marketed devices.
8. The sample size for the training set
Not applicable. This is not an AI/ML device that requires a training set.
9. How the ground truth for the training set was established
Not applicable. This is not an AI/ML device that requires a training set or ground truth establishment in that context.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
November 9, 2018
Omron Healthcare, Inc. % Paul Dryden Consultant ProMedic, LLC. 131 Bay Point Dr. NE St. Petersburg, Florida 33704
Re: K181992
Trade/Device Name: Heat Pain Pro Model PM311B Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous Electrical Nerve Stimulator For Pain Relief Regulatory Class: Class II Product Code: NUH, NYN Dated: October 9, 2018 Received: October 10, 2018
Dear Paul Dryden:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You mav, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be avare that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Pamela D. Scott -S
for Carlos L. Peña, PhD, MS Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K181992
Device Name Heat Pain Pro Model PM311B
Indications for Use (Describe)
The Omron Heat Pain Pro Model PM311B is intended for:
The relief of pain associated with sore or aching, musices of the lower back, arm, legs, shoulder, or foot due to strain from exercise or normal household work activities.
When used for the symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis, use the Tap, Shoulder, Arm or Leg mode of stimulation.
Environment of Use: Clinics, hospital and home environments.
Patient Population: Adult
Type of Use (Select one or both, as applicable)Prescription Use (Part 21 CFR 801 Subpart D)
|X | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
| 510(k) Summary | |
|---|---|
| Date: | November 8, 2018 |
| Sponsor:Omron Healthcare, Inc.1925 West Field CourtLake Forest, IL 60045 USA | Tel - 847-247-5626Fax- 847-680-6269 |
| Official Contact: | Renee Thornborough – Executive Director QA/RA |
| Proprietary or Trade Name: | Heat Pain Pro Model PM311B |
| Common/Usual Name: | Transcutaneous electrical nerve stimulator for pain relief |
| CFR / Code / Classification Name / Class: | 21CFR 882.5890NUH - stimulator, nerve, transcutaneous, over-the-counterNYN - stimulator, electrical, transcutaneous, for arthritisClass II |
| Device Name: | Heat Pain Pro Model PM311B |
| Primary Predicate:Secondary Predicate: | K160115– Omron – Heat Pain Pro (Model PM311)K172079- Omron - Avail (PM601) |
510/1-) C---------------------------------------------------------------------------------------------------------------------------------------------------------------------
Device Description:
The Heat Pain Pro (PM311B) is a small battery operated OTC device that provides a combination of transcutaneous electrical nerve stimulation (TENS) for pain relief and superficial heat for a warming sensation. It delivers TENS only or alternating combinations of TENS and heat are never applied at the same time. The device can connect to a specified external IEC 60601-1 compliant power supply for charging of the internal lithium ion batterv. The device complies with AAMI/ ANSI/ES60601-1, IEC 60601-1-2 and IEC 60601-2-10.
Stimulation from PM311B is intended for application to the following areas: lower back, arms, legs, shoulder or foot. Software controls and indicators. Software controls waveform characteristics.
The Omron Heat Pain Pro Model PM311B is intended for:
- The relief of pain associated with sore or aching, muscles of the lower back, arms, legs, shoulder, . or foot due to strain from exercise or normal household work activities.
- . When used for the symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis, use the Tap, Shoulder, Arm or Leg mode of stimulation.
The accessories include: An external power adaptor, an electrode cord / cable attached to electrodes pads and a Pad holder for storage. The electrode pads Omron "HV-PAD with PMGEL" allow for stimulation and have resistive elements to provide heat which is powered by the PM311B. These are the identical accessories cleared under K160115 for the Model PM311.
{4}------------------------------------------------
The device is battery powered and can be connected to an external power supply for charging the internal battery. The battery is lithium ion and is not user serviceable or accessible. The only external connections on the device are the power input and the electrode connector there is no connection to any other device.
The PM311B is identical to the PM311 cleared under 510(k) K160115, this submission is for expanded indications under product code NYN.
The PM311 and PM311B are considered - OTC devices.
Patient Population
Adults
Indications for Use:
The Omron Heat Pain Pro Model PM311B is intended for:
The relief of pain associated with sore or aching, muscles of the lower back, arms, legs, shoulder, or foot due to strain from exercise or normal household work activities.
When used for the symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis, use the Tap, Shoulder, Arm or Leg mode of stimulation.
Environment of Use:
Clinics, hospital and home environments
Contraindications:
Do not use this device if you have a cardiac pacemaker, implanted defibrillator, or other implanted metallic or electronic device. Such use could cause electric shock, burns, electrical interference, or death.
Predicate Device Comparison:
The PM311B is compared to the predicates in the device comparison table below.
{5}------------------------------------------------
Device Comparison
| Feature | ProposedOmronPM311B | Primary PredicateOmronPM311K160115 | Secondary PredicateOmronAvailK172079 | Discussion of Differences | |
|---|---|---|---|---|---|
| Indications for Use | The Omron Heat Pain Pro ModelPM311B is intended for the reliefof pain associated with sore oraching, muscles of the lowerback, arms, legs, shoulder, or footdue to strain from exercise ornormal household work activities.When used for the symptomaticrelief and management of chronic,intractable pain and relief of painassociated with arthritis, use theTap, Shoulder, Arm or Leg modeof stimulation. | The Omron Heat Pain Pro isintended for the relief of painassociated with sore or aching,muscles of the lower back, arms,legs, shoulder, or foot due to strainfrom exercise or normal householdwork activities. | The Avail is intended for therelief of pain associated withsore or aching muscles of thelower back, arms, legs,shoulders or feet due to strainfrom exercise or normalhousehold work activities.When used for the symptomaticrelief and management ofchronic, intractable pain andrelief of pain associated witharthritis, use the Tap, Shoulder,Arm or Leg mode of stimulation. | Indications between OmronPM311B and predicatePM311 are identical exceptfor the addition indication forchronic, intractable pain andrelief of pain associated witharthritis which is identical tothat of the Avail. | |
| Environments of Use: Clinics,hospital and home environmentsPatient Population: Adult | Environments of Use: Clinics,hospital and home environmentsPatient Population: Adult | Environments of Use: Clinics,hospital and home environmentsPatient Population: Adult | |||
| Classification - Regulation | 21 CFR §882.5890,Transcutaneous electrical nervestimulator for pain relief | 21 CFR §882.5890.Transcutaneous electrical nervestimulator for pain relief | 21 CFR §882.5890,Transcutaneous electrical nervestimulator for pain relief | Identical | |
| Classification - Product Code | Primary: NUH - Transcutaneouselectrical nerve stimulator forpain reliefSecondary: NYN -Transcutaneouselectrical nerve stimulator forpain relief. | NUH - Transcutaneouselectrical nerve stimulator for painrelief | Primary: NUH - Transcutaneouselectrical nerve stimulator forpain reliefSecondary: NYN -Transcutaneouselectrical nerve stimulator forpain relief. | Proposed device adds productcode NYN | |
| Over-the-Counter (OTC) | Yes | Yes | Yes | Identical to predicate PM311K160115 | |
| Feature | ProposedOmronPM311B | Primary PredicateOmronPM311K160115 | Secondary PredicateOmronAvailK172079 | Discussion of Differences | |
| Power Source(s) | External supply Lithium-ionbattery | External supply Lithium-ionbattery | Lithium-ion battery | Identical to predicate PM311K160115 | |
| - Method of Line Current Isolation | N.A.(internal power source) | N.A.(internal power source) | N.A.(internal power source) | Identical to predicate PM311K160115 | |
| - Patient Leakage Current | --- | --- | --- | --- | |
| - Normal Condition (uA) | 1 | 1 | <10 | Identical to predicate PM311K160115 | |
| - Single Fault Condition (uA) | 5.52 max | 5.52 max | <50 | Identical to predicate PM311K160115 | |
| Average DC current through electrodeswhen device is on but no pulse arebeing applied (uA) | 0 (uA) | 0 (uA) | 0 (uA) | Identical to predicate PM311K160115 | |
| Number of output Modes | -3 Therapies(2 TENS with HEAT combinationtherapies and I TENS therapy)-9 TENS Stimulation Modes-2 Heat Level Settings | -3 Therapies(2 TENS with HEAT combinationtherapies and I TENS therapy)-9 TENS Stimulation Modes-2 Heat Level Settings | 9 TENS modes1 Microcurrent mode | Identical to predicate PM311K160115 | |
| Number of outputchannels | Synchronous orAlternating | 1 ch | 1 ch | 1 ch | Identical to predicate PM311K160115 |
| Method of ChannelIsolation | None | None | None | Identical to predicate PM311K160115 | |
| Regulated Current or Regulated Voltage | Regulated Current | Regulated Current | Regulated Current | Identical to predicate PM311K160115 | |
| Software/Firmware/MicroprocessorControl? | Microprocessor | Microprocessor | Microprocessor | Identical to predicate PM311K160115 | |
| Automatic Overload Trip? | No | No | No | Identical to predicate PM311K160115 | |
| Feature | ProposedOmronPM311B | Primary PredicateOmronPM311K160115 | Secondary PredicateOmronAvailK172079 | Discussion of Differences | |
| Automatic No-Load Trip? | Yes | Yes | Yes | Identical to predicate PM311K160115 | |
| Automatic shut Off? | Yes | Yes | Yes | Identical to predicate PM311K160115 | |
| User over ride control? | User activated On/Off | User activated On/Off | Yes, Power On/Off button on thedevice and in the App software | Identical to predicate PM311K160115 | |
| Indication display ON/Off status? | Yes | Yes | Yes on App and LEDindicator on main unit | Identical to predicate PM311K160115 | |
| Low Battery? | Yes | Yes | Yes on App | Identical to predicate PM311K160115 | |
| Voltage / CurrentLevel? | Yes | Yes | Yes on App | Identical to predicate PM311K160115 | |
| Timer Range (minutes) | 30 | 30 | 5-60 (minutes) and30-180 (minutes) | Identical to predicate PM311K160115 | |
| Compliance with Voluntary standards? | ES60601-1, IEC60601-1-2,IEC60601-2-10, IEC 60601-1-11 | ES60601-1, IEC60601-1-2,IEC60601-2-10, IEC 60601-1-11 | ES60601-1, IEC60601-1-2,IEC60601-2-10, IEC 60601-1-11 | Identical to predicate PM311K160115 | |
| Compliance with 21 CFR 898? | Yes | Yes | N/A (no patient cable) | Identical to predicate PM311K160115 | |
| Weight | Approx. 200g (incl. batteries) | Approx. 200g (incl. batteries) | Approx 42g | Identical to predicate PM311K160115 | |
| Dimensions (W x H x D) | 71(W)x165(H)x30.5(D)mm | 71(W)x165(H)x30.5(D)mm | Device: Approx. 60 × 72 ×15.5mm | Identical to predicate PM311K160115 | |
| Operating and Storage Temperature,Humidity | Operating10 to 40°C30 to 80 %RH700 to 1060 hPaStorage,0 to 40°C30 to 80 %RH700 to 1060 hPa | Operating,10 to 40°C30 to 80 %RH700 to 1060 hPaStorage0 to 40°C30 to 80 %RH700 to 1060 hPa | Operating10 to 40 °C30 to 80 %RH700 to 1060 hPa (non-condensing) | Identical to predicate PM311K160115 | |
| Feature | ProposedOmronPM311B | Primary PredicateOmronPM311K160115 | Secondary PredicateOmronAvailK172079 | Discussion of Differences | |
| Transportation Temperature,Humidity, Air Pressure | -20 to 60°C10 to 95% RH,700 to 1060 hPa | -20 to 60°C10 to 95% RH,700 to 1060 hPa | -20 to 60 °C10 to 95% RH,700 to 1060 hPa (non-condensing) | Identical to predicate PM311K160115 | |
| Electrode style | PMGELReusable | PMGELReusable | HV-WPAD-M or HV-WPAD-LReusable | Identical to predicate PM311K160115 | |
| Patient contacting accessory | Electrode | Electrode | Electrode | Identical to predicate PM311K160115 |
{6}------------------------------------------------
K181992 510(k) Summary
{7}------------------------------------------------
{8}------------------------------------------------
Differences Between Other Legally Marketed Predicate Devices:
The Omron PM311B is viewed as substantially equivalent to the predicate devices because: The PM311B uses the exact same technology and has substantially equivalent indications for use. The differences that exist between the devices does not raise of safety or effectiveness.
Indications -
The indications for the PM311B have added "When used for the symptomatic relief and management of chronic, intractable pain and relief of pain associated with arthritis, use the Tap, Shoulder, Arm or Leg mode of stimulation," when compared to predicate PM311 ( K1601 15). The added indication is identical to the predicate Avail (K172079).
Prescriptive -
The PM311B and predicates are all OTC.
Design and Technology -
The PM311B is identical to the PM311 (K160115) and has equivalent design and features when compared to the Omron Avail (K172079).
Performance and Specifications -
The PM311B is identical to the PM311 (K160115) and has equivalent performance specifications when compared to the Omron Avail (K172079).
{9}------------------------------------------------
Patient Population -
The PM311B and predicates are indicated for adults
Environment of Use -
Clinics, hospital and home environments are identical to the predicates.
Non-Clinical Testing Summary:
Compliance with standards -
The PM 311B and predicates comply with the same standards: AAMI ANSI ES6060-1, IEC 60601-1-2, IEC 60601-2-10, and IEC 60601-1-11
The device has been tested to ensure that all requirements have been met, this includes:
- . Testing of all controls
- Testing of all indicators ●
- Testing of battery state indicators ●
- Testing of waveforms ●
The device has also been tested to the requirements of the following standards:
- AAMI / ANSI ES60601-1:2005 + A1: 2012 Medical electrical equipment part 1: ● general requirements for basic safety and essential performance
- . IEC 60601-1-2: 2014 Medical Electrical Equipment - Part 1-2: General Requirements for Safety - Collateral standard: Electromagnetic disturbances - Requirements and Tests
- IEC 60601-1-11: 2015, medical electrical equipment part 1-11: general requirements . for basic safety and essential performance - collateral standard: requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment
- . IEC 60601-2-10: 2016 Medical electrical equipment - part 2-10: particular requirements for the basic safety and essential performance of nerve and muscle stimulators
The device has also been tested for drop, vibration and environmental temperature and humidity as part of IEC 60601-1-11.
Patient Contacting Materials -
The patient contacting materials of the PM311B are the PM-GELs. The PM-GELs are exactly the same as cleared with the PM311( K160115).
Clinical Testing Summary:
No clinical testing was performed
Substantial Equivalence Conclusion
Omron maintains that the PM311B is substantially equivalent to the predicate devices in indications for use, patient population, and environment for use, technology characteristics, specifications / performance and compliance with international standards.
{10}------------------------------------------------
Output of Subject device PM311B
Output Specification Comparison
| Parameter | PM311B | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mode of Program Name | Tap | Knead | Rub | Arm | Lback | Leg | Foot | Joint | Shldr | |
| Waveform | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | |
| Shape | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | |
| Maximum Output Voltage [V] | @500Ω | 67.2 | 40.7 | 37.3 | 67.1 | 67.1 | 66.4 | 66.9 | 40.3 | 67.1 |
| @2kΩ | 85.6 | 56.6 | 51.2 | 86.0 | 84.0 | 85.5 | 85.9 | 56.8 | 84.8 | |
| @10kΩ | 95.9 | 62.4 | 56.7 | 95.7 | 94.0 | 95.5 | 95.8 | 63.1 | 95.4 | |
| Maximum Output Current [mA] | @500Ω | 134.4 | 81.4 | 74.6 | 134.2 | 134.2 | 132.8 | 133.8 | 80.6 | 134.2 |
| @2kΩ | 42.8 | 28.3 | 25.6 | 43.0 | 42.0 | 42.8 | 43.0 | 28.4 | 42.4 | |
| @10kΩ | 9.6 | 6.2 | 5.7 | 9.6 | 9.4 | 9.6 | 9.6 | 6.3 | 9.5 | |
| Duration of primary phase [usec] | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | |
| Pulse Duration [usec] | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | |
| Frequency [Hz] | 1 - 20.13 | 51.65 | 99 | 2 - 51.65 | 2 - 108 | 2 - 51.65 | 2-11 | 42.43 - 108 | 1 - 19 | |
| For multiphasic waveforms only: | Symmetrical phases | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Phase Duration | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Net Charge(µC per pulse) (@500Ω) [µC] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Maximum Phase Charge (@500Ω) [µC] | 12.90 | 7.81 | 7.16 | 12.88 | 12.88 | 12.75 | 12.84 | 7.74 | 12.88 | |
| Maximum Current Density (@500Ω) [mA/cm2] r.m.s. | 0.52 | 0.36 | 0.46 | 0.59 | 0.86 | 0.83 | 0.39 | 0.73 | 0.51 | |
| Maximum Average Current (average absolute value), mA | 0.52 | 0.40 | 0.71 | 0.67 | 1.39 | 1.32 | 0.28 | 1.67 | 0.49 | |
| Maximum Average Power Density (@500Ω) [W/cm²] | 2.19E-03 | 1.03E-03 | 1.66E-03 | 2.80E-03 | 5.85E-03 | 5.48E-03 | 1.19E-03 | 4.22E-03 | 2.06E-03 | |
| Burst Mode | (a) Pulses per burst | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| (b) Bursts per second | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| (c) Burst duration | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| (d) Duty cycle: Line(b)xLine(c) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| ON Time (seconds) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| OFF Time (seconds) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Additional Features | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
{11}------------------------------------------------
Output of Predicate Heat Pain Pro (K16011) with revised values Output Specification Comparison
| Parameter | PM311B | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mode of Program Name | Tap | Knead | Rub | Arm | Lback | Leg | Foot | Joint | Shldr | |
| Waveform | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | |
| Shape | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | |
| Maximum Output Voltage [V] | @500Ω | 67.2 | 40.7 | 37.3 | 67.1 | 67.1 | 66.4 | 66.9 | 40.3 | 67.1 |
| @2kΩ | 85.6 | 56.6 | 51.2 | 86.0 | 84.0 | 85.5 | 85.9 | 56.8 | 84.8 | |
| @10kΩ | 95.9 | 62.4 | 56.7 | 95.7 | 94.0 | 95.5 | 95.8 | 63.1 | 95.4 | |
| @500Ω | 134.4 | 81.4 | 74.6 | 134.2 | 134.2 | 132.8 | 133.8 | 80.6 | 134.2 | |
| Maximum Output Current [mA] | @2kΩ | 42.8 | 28.3 | 25.6 | 43.0 | 42.0 | 42.8 | 43.0 | 28.4 | 42.4 |
| @10kΩ | 9.6 | 6.2 | 5.7 | 9.6 | 9.4 | 9.6 | 9.6 | 6.3 | ||
| Duration of primary phase [usec] | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | ||
| Pulse Duration [usec] | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | |
| Frequency [Hz] | 1 - 20.13 | 51.65 | 99 | 2 - 51.65 | 2 - 108 | 2 - 51.65 | 2-11 | 42.43 - 108 | 1 - 19 | |
| For multiphasic waveforms only: | Symmetrical phases | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Phase Duration | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Net Charge(µC per pulse) (@500Ω) [µC] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Maximum Phase Charge (@500Ω) [µC] | 12.90 | 7.81 | 7.16 | 12.88 | 12.88 | 12.75 | 12.84 | 7.74 | 12.88 | |
| Maximum Current Density (@500Ω) [mA/cm2] r.m.s. | 0.52 | 0.36 | 0.46 | 0.59 | 0.86 | 0.83 | 0.39 | 0.73 | 0.51 | |
| Maximum Average Current (average absolute value), mA | 0.52 | 0.40 | 0.71 | 0.67 | 1.39 | 1.32 | 0.28 | 1.67 | 0.49 | |
| Maximum Average Power Density (@500Ω) [W/cm²] | 2.19E-03 | 1.03E-03 | 1.66E-03 | 2.80E-03 | 5.85E-03 | 5.48E-03 | 1.19E-03 | 4.22E-03 | 2.06E-03 | |
| Burst Mode | (a) Pulses per burst | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| (b) Bursts per second | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| (c) Burst duration | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| (d) Duty cycle: Line(b)xLine(c) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| ON Time (seconds) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| OFF Time (seconds) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Additional Features | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
{12}------------------------------------------------
Output of Reference Avail (K172079)
Output Specification Comparison
| Parameter | Avail(K172079) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mode of Program Name | Steady | AcupunctureLike | Knead | Tap | Lower Back | Shoulder | Joint | Leg | Arm | Microcurrent | |
| Waveform | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | Biphasic | |
| Shape | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | Rectangular | |
| Maximum Output Voltage [V] | @500Ω | 25.9 | 38.4 | 27.9 | 38.3 | 38.2 | 38.4 | 25.6 | 36.7 | 38.2 | 0.025 |
| @2kΩ | 45.2 | 50.8 | 37.2 | 50.3 | 50.4 | 50.4 | 35.7 | 49.5 | 50.4 | 0.100 | |
| @10kΩ | 59.9 | 55.2 | 40.7 | 54.9 | 55.8 | 55.8 | 39.2 | 54.6 | 55.2 | 0.500 | |
| @500Ω | 51.8 | 76.8 | 55.8 | 76.6 | 76.4 | 76.8 | 51.2 | 73.4 | 76.4 | 0.050 | |
| Maximum Output Current [mA] | @2kΩ | 22.6 | 25.4 | 18.6 | 25.2 | 25.2 | 25.2 | 17.9 | 24.8 | 25.2 | 0.050 |
| @10kΩ | 6.0 | 5.5 | 4.1 | 5.5 | 5.6 | 5.6 | 3.9 | 5.5 | 5.5 | 0.050 | |
| Duration of primary phase [μsec] | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 2500000 | |
| Pulse Duration [μsec] | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 2500000 | |
| Frequency [Hz] | 99 | 2 | 51.65 | 1-20.13 | 2-108 | 1-19 | 42.43-108 | 2-51.65 | 2-51.65 | 0.2 | |
| For multiphasic waveforms only: | Symmetrical phases | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Phase Duration | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Net Charge(μC per pulse) (@500Ω) [μC] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Maximum Phase Charge (@500Ω) [μC] | 4.97 | 7.37 | 5.36 | 7.35 | 7.33 | 7.37 | 4.92 | 7.05 | 7.33 | 125.00 | |
| Maximum Current Density (@500Ω) [mA/cm2] r.m.s. | 0.16 | 0.03 | 0.09 | 0.11 | 0.17 | 0.10 | 0.12 | 0.12 | 0.12 | 0.00 | |
| Maximum Average Current (average absolute value), mA | 0.98 | 0.03 | 0.28 | 0.30 | 0.79 | 0.28 | 0.53 | 0.36 | 0.38 | 0.03 | |
| Maximum Average Power Density (@500Ω) [W/cm²] | 5.71E-04 | 2.53E-05 | 1.73E-04 | 2.54E-04 | 6.77E-04 | 2.41E-04 | 3.04E-04 | 2.99E-04 | 3.24E-04 | 1.40E-08 | |
| Burst Mode | (a) Pulses per burst | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| (b) Bursts per second | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| (c) Burst duration | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| (d) Duty cycle: Line(b)xLine(c) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| ON Time (seconds) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| OFF Time (seconds) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| Additional Features | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
§ 882.5890 Transcutaneous electrical nerve stimulator for pain relief.
(a)
Identification. A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.(b)
Classification. Class II (performance standards).